ISMP and the FDA have received numerous reports of wrong dose errors with Paxlovid, which is indicated for treatment of mild-to-moderate COVID-19 in adults and pediatric patients. This week’s featured ISMP newsletter article provides safe practice recommendations: https://www.ismp.org/node/32452